enGene Holdings: A Potential Oncology Entrant [Seeking Alpha]
enGene Holdings Inc. (ENGN)
Company Research
Source: Seeking Alpha
ENGN's DDX gene delivery platform enables localized, multi-gene non-viral therapies, aiming to overcome immunogenicity and toxicity challenges. Despite promising data, the efficacy is comparable but not superior to leading competitors, and the NMIBC market is becoming crowded. Getty Images Shares of bladder cancer gene therapy concern enGene Holdings Inc. ( ENGN ) rallied over 50% after providing data from its protocol-revised pivotal cohort of a Phase 2 trial on November 10, 2025. The results were encouraging with a More on my IG service Live Chat on The Biotech Forum sees frequent discussion of specific covered call trades. To see what covered call trades I am currently executing along with a model portfolio of attractive biotech stocks, just initiate your free trial into The Biotech Forum by clicking HERE This article was written by Analyst's Disclosure: I/we have a beneficial long position in the shares of CGON, IBRX either through stock ownership, options, or other
Show less
Read more
Impact Snapshot
Event Time:
ENGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ENGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ENGN alerts
High impacting enGene Holdings Inc. news events
Weekly update
A roundup of the hottest topics
ENGN
News
- enGene Reports Full Year 2025 Financial Results and Provides Business Update [Yahoo! Finance]Yahoo! Finance
- enGene Reports Full Year 2025 Financial Results and Provides Business UpdateBusiness Wire
- enGene Holdings Inc (ENGN) Surging After Positive Phase 2 LEGEND Trial [Yahoo! Finance]Yahoo! Finance
- enGene (NASDAQ:ENGN) had its "buy" rating reaffirmed by analysts at HC Wainwright.MarketBeat
- enGene’s Detalimogene Selected for FDA Manufacturing Pilot Program to Support Manufacturing ReadinessBusiness Wire
ENGN
Sec Filings
- 12/22/25 - Form 10-K
- 12/22/25 - Form 8-K
- 11/18/25 - Form SCHEDULE
- ENGN's page on the SEC website